Funding for this research was provided by:
National Institutes of Health (R44 CA126461, R01 CA90873, R43 CA126461, R01 AI096879, R01 CA104947-S1, R01 AI129543-01, P01 CA154778, R01 CA104947)
Received: 4 March 2017
Accepted: 3 October 2017
First Online: 20 October 2017
Change Date: 20 December 2017
Change Type: Correction
Change Details: The authors would like to make the following corrections to the published article.
Compliance with ethical standards
: Author Joseph I. Clark received speaking honorariums from Merck and Bristol-Myers Squibb, and is an unpaid member of the steering committee for the Prometheus PROCLAIM high-dose IL-2 database. Other authors report no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.